Videos and podcasts
International Biotechnology Trust plc - IBTAilsa Craig sets out the huge opportunity in the biotech space and how the trust's strategy can benefit from this. Ailsa also touches on the current political backdrop for biotech and how M&A has contributed to impressive returns recently.
IBT portfolio manager Ailsa Craig talked with Proactive’s Stephen Gunnion about the trust’s recent outperformance, the resurgence of biotech markets, and why merger and acquisition (M&A) activity is becoming a key driver of returns.
Portfolio Manager Ailsa Craig presented on IBT as part of Kepler's 'Ideas for your ISA' webinar series
Portfolio Managers Ailsa and Marek give their outlook for the biotech sector in 2026
QuotedData's James Carthew hosts a panel discussion between International Biotechnology Trust, Invesco Bond Income Plus and Aberdeen Equity Income Trust on income funds for ISA
Ailsa Craig discusses the broad opportunity in the biotech sector, where IBT's portfolio is focused, and the impact of AI
Portfolio Managers Ailsa and Marek present the annual results of the trust for the year ended 31 August 2025
Portfolio Managers Ailsa and Marek present the annual results of the trust for the year ended 31 August 2025
Jonathan Davis takes a look at the biotech sector and speaks to Ailsa Craig, Woody Stileman and Geoffrey Hsu
Biotech 2.0: Navigating risk and discovering value in a sector poised for recovery
We discuss the big picture market insights with leading investment experts
Ailsa and Marek discuss recent performance, portfolio allocation and the most exciting opportunities in the biotech sector
Marek Poszepczynski gives an introduction to the International Biotechnology Trust plc and discusses M&A in the sector